Eric Richman, CEO of Gain Therapeutics, discusses its platform technology, how it works, and why it offers a compelling alternative to other approaches to treating lysosomal storage disorders.

Bringing Aberrant Proteins Back into the Fold

<p>RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy. </p>

Business

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Share Bringing Aberrant Proteins Back into the Fold

Sign up to save your podcasts

Bringing Aberrant Proteins Back into the Fold

Bringing Aberrant Proteins Back into the Fold